WHO Commission on Intellectual Property Rights, Innovation and Public Health
Background to WHO involvement in IP; rising concern about price barriers associated with restrictive intellectual property laws and also failure to develop drugs for neglected diseases.
Commissioning of the commission, terms of reference, membership etc
Over view of findings and recommendations
Weak or strong standards